Skip to content

VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer

Videoendoscopic Radical Inguinal Lymphadenectomy Versus Open Radical Inguinal Lymphadenectomy in Patients With Penile Cancer: a Feasibility Randomised Controlled Trial

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05592639
Acronym
VELRAD
Enrollment
50
Registered
2022-10-25
Start date
2022-06-23
Completion date
2025-07-31
Last updated
2025-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Lymphadenopathy, Melanoma, Penile Cancer

Brief summary

Assess the feasibility of performing a RCT comparing videoendoscopic radical inguinal lymphadenectomy versus open radical inguinal lymphadenectomy in men diagnosed with genital cancer requiring inguinal lymphadenectomy, and determine the design of such an RCT.

Detailed description

There is increasing interest in using videoendoscopic inguinal lymph node dissection (ILND) as an alternative to open ILND. Videoendoscopic inguinal lymphadenectomy (VEIL) may decrease complications compared to open ILND and provide equivalent short-term oncological outcomes. As yet, there have been no randomised-controlled trials (RCTs) comparing these procedures. VELRAD aims to assess the feasibility of performing a RCT comparing VEIL and open ILND. This will be measured by recruitment rate, the acceptability of the trial design and intervention to clinical stage and patients. Investigators will also collect qualitative data on why patients did or did not agree to be randomised

Interventions

PROCEDUREVideoendoscopic radical inguinal lymphadenectomy or open radical inguinal lymphadenectomy

Intervention is a Videoendoscopic radical inguinal lymphadenectomy (VEIL) which is a surgical technique utilised in removing inguinal lymph nodes.

Sponsors

The Christie NHS Foundation Trust
CollaboratorOTHER
St George's University Hospitals NHS Foundation Trust
CollaboratorOTHER
Norfolk and Norwich University Hospitals NHS Foundation Trust
CollaboratorOTHER
University College, London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. People requiring inguinal lymphadenectomy i.e. 1. Patients with squamous cell carcinoma or mucosal melanoma of the penis \> T1bG2 or patients with male genital cancer requiring inguinal lymphadenectomy 2. Patients unsuitable for dynamic sentinel node biopsy (DSNB) with impalpable nodes: previous penectomy or non-visualisation at previous DSNB 3. Previous DSNB with metastatic inguinal nodes on histology or FNA positive nodes on cytology who require a completion radical inguinal lymphadenectomy 4. Small volume palpable inguinal lymph nodes (\< 2 cm on CT) not fixed to skin 2. Age \> 18 years

Exclusion criteria

1. Unfit for surgery 2. People unlikely to benefit from lymphadenectomy because of advanced cancer 3. Those with palpable inguinal lymph nodes fixed to skin or adjacent structures 4. Does not want to participate in the trial or unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Ability to recruit patients18 monthsAbility to recruit patients at the selected sites (recruitment rate)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026